Logo for Alexion Pharmaceuticals Inc

Alexion Pharmaceuticals Investor Relations Material

Latest events

Logo for Alexion Pharmaceuticals

Q4 2020

8 Feb, 2021
Logo for Alexion Pharmaceuticals

Q4 2019

4 Feb, 2020
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Alexion Pharmaceuticals Inc

Access all reports
Alexion Pharmaceuticals Inc focused on the development and commercialization of therapies for rare diseases. The company specialized in biologics targeting immune-mediated rare conditions and offered treatments across neurology, hematology, nephrology, and metabolic disorders. Alexion operated globally through research, manufacturing, and commercial networks. The company was headquartered in Boston, Massachusetts, and its shares were listed on the NASDAQ.